IDEXX Laboratories, Inc. (IDXX)
538.99
-6.17
(-1.13%)
USD |
NASDAQ |
Sep 02, 16:00
538.89
-0.10
(-0.02%)
After-Hours: 20:00
IDEXX Laboratories Gross Profit Margin (Quarterly) : 64.07% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 64.07% |
| March 31, 2026 | 63.37% |
| December 31, 2025 | 60.47% |
| September 30, 2025 | 62.01% |
| June 30, 2025 | 62.51% |
| March 31, 2025 | 62.81% |
| December 31, 2024 | 59.50% |
| September 30, 2024 | 61.05% |
| June 30, 2024 | 61.87% |
| March 31, 2024 | 61.60% |
| December 31, 2023 | 58.16% |
| September 30, 2023 | 59.72% |
| June 30, 2023 | 60.72% |
| March 31, 2023 | 60.28% |
| December 31, 2022 | 57.43% |
| September 30, 2022 | 59.17% |
| June 30, 2022 | 59.06% |
| March 31, 2022 | 59.35% |
| December 31, 2021 | 57.02% |
| September 30, 2021 | 58.55% |
| June 30, 2021 | 59.56% |
| March 31, 2021 | 60.85% |
| December 31, 2020 | 57.04% |
| September 30, 2020 | 58.47% |
| June 30, 2020 | 59.21% |
| Date | Value |
|---|---|
| March 31, 2020 | 57.20% |
| December 31, 2019 | 54.11% |
| September 30, 2019 | 56.46% |
| June 30, 2019 | 57.30% |
| March 31, 2019 | 57.32% |
| December 31, 2018 | 54.41% |
| September 30, 2018 | 55.99% |
| June 30, 2018 | 57.39% |
| March 31, 2018 | 56.72% |
| December 31, 2017 | 54.02% |
| September 30, 2017 | 55.88% |
| June 30, 2017 | 57.37% |
| March 31, 2017 | 55.65% |
| December 31, 2016 | 53.85% |
| September 30, 2016 | 54.89% |
| June 30, 2016 | 55.82% |
| March 31, 2016 | 54.30% |
| December 31, 2015 | 52.88% |
| September 30, 2015 | 53.96% |
| June 30, 2015 | 55.09% |
| March 31, 2015 | 55.18% |
| December 31, 2014 | 50.92% |
| September 30, 2014 | 55.48% |
| June 30, 2014 | 56.04% |
| March 31, 2014 | 55.98% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| DexCom, Inc. | 63.44% |
| Intuitive Surgical, Inc. | 67.76% |
| Abbott Laboratories | 52.64% |
| Align Technology, Inc. | 71.71% |
| Integra LifeSciences Holdings Corp. | 54.87% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 73.11% |
| Return on Assets | 33.73% |
| Return on Invested Capital | 42.77% |
| Profit Margin (Quarterly) | 27.82% |
| Operating Margin (Quarterly) | 35.02% |
| Return on Net Operating Assets | 45.59% |